Metraipolis › archive › dc_357197bb41f3
Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes — Europe PMC PMID:41917547
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41917547
- DOI
- 10.1007/s11060-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T14:36:52.374Z
- SHA-256 of the archived text
f6961bc3f6058e96d50e00d7d83b72b80d79fff5ae0d2c69eaa5740942832cba- Stable URL of this page
https://metraipolis.com/documento/dc_357197bb41f3
How to cite
Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes — Europe PMC PMID:41917547 — Europe PMC (en), https://europepmc.org/article/MED/41917547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_357197bb41f3 (Metraipolis archive dc_357197bb41f3, sha256 f6961bc3f6058e96d50e00d7d83b72b80d79fff5ae0d2c69eaa5740942832cba)
BibTeX
@misc{dc357197bb41f3,
title = {Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes — Europe PMC PMID:41917547},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41917547},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_357197bb41f3; sha256 f6961bc3f6058e96d50e00d7d83b72b80d79fff5ae0d2c69eaa5740942832cba},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41917547. Agents can read the archived copy with the MCP tool read_document.